May 12, 2022 / 12:20AM GMT
Craig William Bijou - BofA Securities, Research Division - Research Analyst
Good afternoon. My name is Craig Bijou, one of the medtech analysts here at BofA. And it's a pleasure to welcome Silk Road. And from the company, I have Erica Rogers, CEO; and Lucas Buchanan, CFO. So Erica, Lucas, welcome. Thank you for coming.
Lucas W. Buchanan - Silk Road Medical, Inc - CFO & COO
Thank you.
Erica J. Rogers - Silk Road Medical, Inc - President, CEO & Director
Good to meet you, Craig. Thanks very much.
Questions and Answers:
Craig William Bijou - BofA Securities, Research Division - Research AnalystI want to start with just Q1, kind of focus there before getting to some of the bigger picture excitement that you guys have going on. But, obviously, January and February were challenging for you guys, for everyone. March rebounded. And, I guess, maybe with that, what do you see as the bigger impact on TCAR specifically? Is it elective procedure impact? Is it staffing? And
Trustpilot
